Emerson Electric Co.(EMR)Stock Performance & ReturnsNYSE
Returns, drawdowns and benchmark comparison
Peer Comparison
Relative scale, growth, and profitability vs sector peers
| Ticker | Market Cap | P/E Ratio | Revenue Growth | Net Margin | EPS | ROE | Debt/Equity | Dividend Yield | 52W High | 52W Low |
|---|---|---|---|---|---|---|---|---|---|---|
EMR | 88.81 B | 34.02x | 7.00% | 13.83% | $4.68 | 12.80% | 0.68x | 1.38% | $166.35 | $122.64 |
3665.TW | 460.39 B | 43.37x | 37.50% | 12.90% | $54.42 | 24.66% | 0.36x | 0.59% | $2983.85 | $991.31 |
VRT | 94.90 B | 54.78x | 24.10% | 15.09% | $4.50 | 43.94% | 0.70x | 0.07% | $379.76 | $147.72 |
AME | 57.00 B | 36.19x | 15.00% | 20.04% | $6.87 | 14.56% | 0.21x | 0.52% | $260.78 | $178.15 |
ROK | 49.17 B | 41.45x | 7.90% | 13.39% | $10.66 | 30.63% | 1.03x | 1.23% | $495.83 | $328.32 |
Peer Valuation & Performance Analysis
Peer group analysis for Emerson Electric Co. (EMR) compared to its primary competitors (including 3665.TW, VRT, AME) reveals distinct metrics. EMR trades at a valuation discount relative to its competitors, with a P/E ratio of 34.0x versus the peer average of 43.9x (representing a 23% discount). This discount might represent an undervalued entry opportunity or reflect specific risk factors the market is discounting. In terms of growth, EMR's revenue growth of 7.0% lags behind the peer average of 21.1%, indicating potential market share losses or slower industry adoption. Additionally, its net margin of 13.8% is comparable to the peer average of 15.4%.
Peer Performance Rankings
Ranking comparison across key performance metrics
P/E Ratio (Lower is Better)
Revenue Growth
Net Profit Margin
Financial Rankings Summary
• EMR ranks #1 in P/E ratio, #5 in revenue growth, and #3 in profit margins
• Average ranking: #3 - 📊 Solid financials relative to peer group
• Rankings based on actual financial data from company reports
Historical Trading Data
Price and volume data with customizable timeframes
Showing 15 of 15 trading sessions from the last 15 days
| Date | Open | High | Low | Close | Volume | Daily Change |
|---|---|---|---|---|---|---|
| 2026-10-07 | $158.35 | $161.55 | $157.59 | $159.22 | 3,039,800 | -1.35% |
| 2026-10-06 | $163.25 | $165.24 | $161.15 | $161.40 | 2,856,100 | -0.57% |
| 2026-10-05 | $161.74 | $164.21 | $160.99 | $162.33 | 2,139,300 | +0.45% |
| 2026-10-02 | $161.59 | $164.13 | $160.24 | $161.61 | 2,900,600 | +1.92% |
| 2026-10-01 | $153.35 | $159.18 | $153.10 | $158.57 | 3,341,400 | +2.24% |
| 2026-09-30 | $158.25 | $158.28 | $154.96 | $155.10 | 4,646,200 | -1.36% |
| 2026-09-29 | $160.07 | $160.29 | $156.24 | $157.24 | 2,448,000 | -1.35% |
| 2026-09-28 | $156.64 | $160.13 | $156.57 | $159.39 | 2,140,500 | +0.73% |
| 2026-09-25 | $157.68 | $159.87 | $156.68 | $158.23 | 1,956,200 | +1.34% |
| 2026-09-24 | $152.73 | $156.31 | $152.52 | $156.14 | 2,071,800 | +1.00% |
| 2026-09-23 | $152.99 | $156.01 | $152.99 | $154.59 | 2,722,800 | +0.26% |
| 2026-09-22 | $153.20 | $155.11 | $152.50 | $154.19 | 1,866,900 | +1.63% |
| 2026-09-21 | $151.08 | $152.25 | $149.69 | $151.72 | 2,103,700 | +1.20% |
| 2026-09-18 | $147.60 | $149.99 | $147.12 | $149.92 | 3,925,200 | +1.71% |
| 2026-09-17 | $149.21 | $149.36 | $146.83 | $147.40 | 2,031,000 | +1.08% |
Explore More Analysis for EMR
Additional research, tools, and technical breakdowns
Stock Analyzer Report
Deep-dive automated research and stock rating report.
DCF Fair Value Calculator
Discounted cash flow model and intrinsic value projection.
AI Price Predictions
Multi-scenario price predictions and consensus targets.
Insider Activity Tracker
Track buying/selling behavior of corporate insiders.
Earnings Calendar
Track upcoming and historical corporate earnings reports.
Market Insights & Research
Read the latest analysis articles and expert research.